| Final Research Plan: Vision Screening in Children Ages 6 Months to 5 Years |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Syphilis Infection in Nonpregnant Adults and Adolescents |
|
| Public Comment on Draft Research Plan: Interventions for Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Skin Cancer |
|
| USPSTF Releases Fifth Annual Report to Congress |
|
| Final Research Plan: Screening to Prevent Osteoporotic Fractures |
|
| Final Research Plan: Screening for Cervical Cancer |
|
| Public Comment on Draft Research Plan: Screening for Prostate Cancer |
|
| Final Recommendation Statement: Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus |
|
| Final Research Plan: Interventions to Prevent Falls in Older Adults |
|
| Final Research Plan: Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions |
|
| Final Recommendation Statement: Screening for High Blood Pressure in Adults |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Colorectal Cancer |
|
| Public Comment on Draft Research Plan: Screening for Adolescent Idiopathic Scoliosis |
|
| Public Comment on Draft Research Plan: Screening for Visual Impairment in Children Ages 6 Months to 5 Years |
|
| Final Recommendation Statement: Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Summaries: Aspirin to Prevent Cardiovascular Disease and Cancer |
|
| Final Recommendation Statements: Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women and Screening for Iron Deficiency Anemia in Young Children |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Depression in Children and Adolescents |
|
| Final Research Plan: Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment |
|
